Pronase treatment increases the staining intensity of GABA-immunoreactive structures in the paravertebral sympathetic ganglia

E. Dobó, P. Kása, R. J. Wenthold, J. R. Wolff

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A novel tissue preparation technique for improving gamma-aminobutyric acid (GABA) immunocytochemistry has been developed. The influence of the glutaraldehyde concentration in the fixative and the effect of pronase treatment on the GABA immunostaining were tested. This method includes fixation with a high concentration of glutaraldehyde, gelatin embedding and treatment of the sections with pronase. In sympathetic (paravertebral) ganglia and their connectives, the most intense and specific immunoreaction was obtained with the following procedure: immersion fixation in 5% glutaraldehyde, infiltration and embedding in 15% gelatin, secondary fixation of the samples with 4% formaldehyde, floating frozen sections and digestion with 0.1% pronase for 15-20 min. With this technique, the GABA-containing structures (cells and nerve fibers with varicosities forming basket-like networks around some principal neurons) were selectively labeled. The data presented suggest that (1) a high concentration (5%) of glutaraldehyde in the primary fixative is necessary to preserve a large proportion of the GABA content; (2) this glutaraldehyde fixation partly masks the GABA immunoreactivity; and (3) this masking may be overcome by a proteolytic treatment preceding the immunostaining. This method has been extensively tested for the light microscopic visualization of GABA-containing tissue components in the sympathetic ganglion chain, but it may probably also be used for the immunocytochemical detection of other small molecules in other parts of the nervous system.

Original languageEnglish
Pages (from-to)13-18
Number of pages6
JournalHistochemistry
Volume93
Issue number1
DOIs
Publication statusPublished - Nov 1989

Fingerprint

Pronase
Sympathetic Ganglia
gamma-Aminobutyric Acid
Glutaral
Staining and Labeling
Fixatives
Gelatin
Therapeutics
Frozen Sections
Immersion
Masks
Nerve Fibers
Nervous System
Formaldehyde
Digestion
Immunohistochemistry
Neurons
Light

ASJC Scopus subject areas

  • Anatomy

Cite this

Pronase treatment increases the staining intensity of GABA-immunoreactive structures in the paravertebral sympathetic ganglia. / Dobó, E.; Kása, P.; Wenthold, R. J.; Wolff, J. R.

In: Histochemistry, Vol. 93, No. 1, 11.1989, p. 13-18.

Research output: Contribution to journalArticle

@article{6ae10399711b461eac353e0964b22b12,
title = "Pronase treatment increases the staining intensity of GABA-immunoreactive structures in the paravertebral sympathetic ganglia",
abstract = "A novel tissue preparation technique for improving gamma-aminobutyric acid (GABA) immunocytochemistry has been developed. The influence of the glutaraldehyde concentration in the fixative and the effect of pronase treatment on the GABA immunostaining were tested. This method includes fixation with a high concentration of glutaraldehyde, gelatin embedding and treatment of the sections with pronase. In sympathetic (paravertebral) ganglia and their connectives, the most intense and specific immunoreaction was obtained with the following procedure: immersion fixation in 5{\%} glutaraldehyde, infiltration and embedding in 15{\%} gelatin, secondary fixation of the samples with 4{\%} formaldehyde, floating frozen sections and digestion with 0.1{\%} pronase for 15-20 min. With this technique, the GABA-containing structures (cells and nerve fibers with varicosities forming basket-like networks around some principal neurons) were selectively labeled. The data presented suggest that (1) a high concentration (5{\%}) of glutaraldehyde in the primary fixative is necessary to preserve a large proportion of the GABA content; (2) this glutaraldehyde fixation partly masks the GABA immunoreactivity; and (3) this masking may be overcome by a proteolytic treatment preceding the immunostaining. This method has been extensively tested for the light microscopic visualization of GABA-containing tissue components in the sympathetic ganglion chain, but it may probably also be used for the immunocytochemical detection of other small molecules in other parts of the nervous system.",
author = "E. Dob{\'o} and P. K{\'a}sa and Wenthold, {R. J.} and Wolff, {J. R.}",
year = "1989",
month = "11",
doi = "10.1007/BF00266841",
language = "English",
volume = "93",
pages = "13--18",
journal = "Histochemie. Histochemistry. Histochimie",
issn = "0948-6143",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Pronase treatment increases the staining intensity of GABA-immunoreactive structures in the paravertebral sympathetic ganglia

AU - Dobó, E.

AU - Kása, P.

AU - Wenthold, R. J.

AU - Wolff, J. R.

PY - 1989/11

Y1 - 1989/11

N2 - A novel tissue preparation technique for improving gamma-aminobutyric acid (GABA) immunocytochemistry has been developed. The influence of the glutaraldehyde concentration in the fixative and the effect of pronase treatment on the GABA immunostaining were tested. This method includes fixation with a high concentration of glutaraldehyde, gelatin embedding and treatment of the sections with pronase. In sympathetic (paravertebral) ganglia and their connectives, the most intense and specific immunoreaction was obtained with the following procedure: immersion fixation in 5% glutaraldehyde, infiltration and embedding in 15% gelatin, secondary fixation of the samples with 4% formaldehyde, floating frozen sections and digestion with 0.1% pronase for 15-20 min. With this technique, the GABA-containing structures (cells and nerve fibers with varicosities forming basket-like networks around some principal neurons) were selectively labeled. The data presented suggest that (1) a high concentration (5%) of glutaraldehyde in the primary fixative is necessary to preserve a large proportion of the GABA content; (2) this glutaraldehyde fixation partly masks the GABA immunoreactivity; and (3) this masking may be overcome by a proteolytic treatment preceding the immunostaining. This method has been extensively tested for the light microscopic visualization of GABA-containing tissue components in the sympathetic ganglion chain, but it may probably also be used for the immunocytochemical detection of other small molecules in other parts of the nervous system.

AB - A novel tissue preparation technique for improving gamma-aminobutyric acid (GABA) immunocytochemistry has been developed. The influence of the glutaraldehyde concentration in the fixative and the effect of pronase treatment on the GABA immunostaining were tested. This method includes fixation with a high concentration of glutaraldehyde, gelatin embedding and treatment of the sections with pronase. In sympathetic (paravertebral) ganglia and their connectives, the most intense and specific immunoreaction was obtained with the following procedure: immersion fixation in 5% glutaraldehyde, infiltration and embedding in 15% gelatin, secondary fixation of the samples with 4% formaldehyde, floating frozen sections and digestion with 0.1% pronase for 15-20 min. With this technique, the GABA-containing structures (cells and nerve fibers with varicosities forming basket-like networks around some principal neurons) were selectively labeled. The data presented suggest that (1) a high concentration (5%) of glutaraldehyde in the primary fixative is necessary to preserve a large proportion of the GABA content; (2) this glutaraldehyde fixation partly masks the GABA immunoreactivity; and (3) this masking may be overcome by a proteolytic treatment preceding the immunostaining. This method has been extensively tested for the light microscopic visualization of GABA-containing tissue components in the sympathetic ganglion chain, but it may probably also be used for the immunocytochemical detection of other small molecules in other parts of the nervous system.

UR - http://www.scopus.com/inward/record.url?scp=0024430007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024430007&partnerID=8YFLogxK

U2 - 10.1007/BF00266841

DO - 10.1007/BF00266841

M3 - Article

C2 - 2482273

AN - SCOPUS:0024430007

VL - 93

SP - 13

EP - 18

JO - Histochemie. Histochemistry. Histochimie

JF - Histochemie. Histochemistry. Histochimie

SN - 0948-6143

IS - 1

ER -